EMAIL DIGESTS
Daily
Every morning
Weekly
Sunday recap
Maruho is a Japanese pharmaceutical company specializing in the development, manufacturing, and distribution of innovative medicines for treating skin diseases.
No recent news for this company.
Sibel Health Closes Series C Extension to $39M Led by Maruho and Samsung Next
Sibel Health Raises $39M in Series C Extension Led by Strategic Investors